MétaCan
Menu
Back to cohort
Record W4416027620 · doi:10.1016/j.puhe.2025.106039

Cardiovascular impact of the national program of publicly-funded access to dapagliflozin in Brazil

2025· article· en· W4416027620 on OpenAlexaff
Gabriella Richter da Natividade, Ravi Retnakaran, Moira K. Kapral, Cristiane Bauermann Leitão, Fernando Gerchman, Caroline K. Kramer

Bibliographic record

VenuePublic Health · 2025
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsPublic Health OntarioUniversity of TorontoLunenfeld-Tanenbaum Research InstituteMount Sinai Hospital
FundersConselho Nacional de Desenvolvimento Científico e TecnológicoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior
KeywordsDapagliflozinPopulationPublic healthPopulation healthAdverse effectMortality rate

Abstract

fetched live from OpenAlex

OBJECTIVES: Sodium-glucose cotransporter-2 inhibitors can reduce the incidence of cardiovascular (CV) events in patients with type 2 diabetes. Financial barriers may preclude their use in clinical practice. The aim of this study is to evaluate the changes in CV events associated with the implementation of the Brazilian national program of publicly-funded access to dapagliflozin in 2021. STUDY DESIGN: Nationwide population-based study. METHODS: A nationwide population-based time-series analysis to examine trends in rates of CV mortality and hospitalizations before (2017-2019) and after (2022-2024) public funding of dapagliflozin was performed. Data were obtained from the Brazilian National Health registry (203,080,756 individuals). RESULTS: As compared to 2017-2019, the mortality rates from CV causes in the Brazilian population reduced in 2022-2024 following the publicly-funded access to dapagliflozin. As compared to 2017, the mortality rate from CV causes decreased by 4.7 % in 2022, 11.4 % in 2023, and 19.1 % in 2024. Importantly, an interrupted time-series analysis indicated that there was a significant change on mortality rates from CV causes between these time periods: slope -0.16 (95 % CI -0.49 to 0.16) for the 2017-2019 time period as compared to -0.74 (95 % CI -1.19 to -0.29, P = 0.039) for 2022-2024 indicating a steeper reduction on the trend of mortality from CV causes after this public health intervention. CONCLUSIONS: There was an important change (reduction) in the trends of adverse CV outcomes following the implementation of a national program of publicly-funded access to dapagliflozin. These data highlight that public health measures that improve affordability of medications can significantly impact mortality rates at a population level.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.319
Threshold uncertainty score0.286

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.002
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.068
GPT teacher head0.420
Teacher spread0.351 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuePublic HealthSame topicDiabetes Treatment and ManagementFrench-language works237,207